LDH-2 Test

When cells are injured or destroyed, they leak enzymes into the bloodstream. One of those enzymes, lactate dehydrogenase (LDH), is so common across body tissues that a high total LDH reading tells you something is wrong but not where. LDH-2 (lactate dehydrogenase isoenzyme 2) narrows the picture. It is one of five LDH isoenzymes, each concentrated in different organs, and its level helps trace the source of damage to specific tissues.

LDH-2 is the most abundant LDH isoenzyme in your blood under normal conditions, primarily released from white blood cells called neutrophils, as well as from heart tissue and the cells lining your blood vessels. When your doctor orders an LDH isoenzyme panel, the pattern of all five isoenzymes, and especially the ratio between LDH-1 and LDH-2, points toward the organ or cell type that is being damaged. This test is most useful when total LDH is already elevated and you need to know why.

What LDH-2 Tells You That Total LDH Cannot

Total LDH rises in dozens of conditions, from heart attacks to liver disease to cancer to a simple blood draw where red blood cells get crushed in the tube. That lack of specificity is its biggest weakness. The isoenzyme breakdown adds a layer of diagnostic precision. LDH-2 sits at the center of that breakdown because it is normally the single largest fraction in healthy serum.

The most clinically studied pattern involves the relationship between LDH-1 and LDH-2. In healthy people, LDH-2 is higher than LDH-1. When heart muscle is damaged, the heart releases large amounts of LDH-1, flipping this normal ratio. This pattern, called the "flipped" LDH-1 to LDH-2 ratio, was once a primary tool for confirming heart attacks, particularly when other markers had already returned to normal.

Heart Attack Diagnosis

Before modern high-sensitivity troponin tests became widely available, the LDH-1 to LDH-2 ratio was a workhorse for diagnosing heart attacks, especially ones detected days after the initial event. In a study of 100 patients, an LDH-1 to LDH-2 ratio above 0.76 identified acute heart attacks with 96% sensitivity (catching 96 out of 100 true cases) and 97% specificity (correctly ruling out 97 out of 100 non-cases). This made it one of the more accurate enzyme tests available at the time, particularly useful when creatine kinase had already returned to normal.

In cardiac surgery patients, the picture becomes more complicated. A study of 79 patients who underwent heart operations found that while the LDH-1 to LDH-2 ratio helped identify perioperative heart attacks (heart attacks occurring during or shortly after surgery), creatine kinase MB (CK-MB, another heart enzyme) was more accurate overall, providing 96% diagnostic accuracy. No combination of enzyme measurements could perfectly distinguish all cases.

Today, high-sensitivity troponin tests have largely replaced LDH isoenzymes for acute heart attack diagnosis because troponin rises faster and is more specific to heart muscle. However, the LDH isoenzyme pattern retains value in situations where the cardiac event happened days earlier and troponin has already returned to normal, or when distinguishing heart damage from other sources of elevated total LDH.

Liver Disease and Neutrophil Destruction

LDH-2 is not only a cardiac marker. Because it is abundant in neutrophils (a type of white blood cell that fights infection), elevated LDH-2 can signal that neutrophils are being destroyed at an unusually high rate. In a study of 172 patients with cirrhosis (severe liver scarring) and chronic hepatitis, researchers found that LDH-1 and LDH-2 levels correlated with a marker of neutrophil destruction called myeloperoxidase (an enzyme released when neutrophils break apart).

This connection pointed to a condition called hypersplenism, where an enlarged spleen traps and destroys blood cells faster than normal. Patients with higher LDH-2 and myeloperoxidase levels also had lower neutrophil and platelet counts, consistent with the spleen clearing these cells from circulation. If you have liver disease and unexpectedly high LDH-2, this pattern may explain why your blood counts are dropping.

Hemolysis and Blood Cell Destruction

LDH isoenzymes help differentiate the source of cell destruction in the blood. When red blood cells rupture (a process called hemolysis, or the breaking apart of red blood cells), LDH-1 typically rises the most because red blood cells are rich in that isoform. But LDH-2 also rises in hemolytic conditions, and the overall isoenzyme pattern helps clinicians determine whether the destruction is coming from red blood cells, white blood cells, or another tissue.

This distinction matters in conditions like sickle cell disease, where elevated total LDH reflects ongoing hemolysis, and in patients with mechanical heart pumps (left ventricular assist devices), where LDH isoenzyme patterns can help distinguish pump-related blood cell damage from other complications like infection or clot formation.

Context From Total LDH Research

Most large-scale outcome research has been conducted on total LDH rather than LDH-2 specifically. These findings provide useful context, though they cannot be directly attributed to LDH-2 alone. Total LDH has been linked to prognosis in multiple cancers, severity of COVID-19 illness, outcomes in sepsis, and mortality risk in kidney disease patients on dialysis. In a study of over 109,000 hemodialysis patients, higher total LDH was associated with increased death risk, while a level around 240 U/L was associated with better survival.

A systems-level analysis across more than 182,000 people found total LDH abnormalities in 48 different disease types. These findings reinforce that LDH is a broad indicator of tissue stress, but they do not tell you which isoenzyme is driving the elevation. That is precisely where the isoenzyme panel, including LDH-2, adds value.

Reference Ranges

There are no universally standardized clinical reference ranges for LDH-2 in isolation. Most labs report LDH isoenzymes as a percentage of total LDH or as absolute activity in U/L (units per liter, a standard measure of enzyme activity). The values you receive depend on the specific separation method your lab uses, whether electrophoresis (separating proteins by electrical charge) or column chromatography (separating by chemical properties), as well as the assay conditions.

One study using column chromatography reported a mean LDH-2 of 250 U/L (with a standard deviation of 34.7 U/L) in a serum control sample. Most clinical labs report LDH-2 as roughly 29% to 39% of total LDH activity, though your lab's specific range may differ. The following table provides general orientation, not absolute targets.

Always compare your results within the same lab over time. Different methods can produce meaningfully different numbers for the same blood sample.

When Results Can Be Misleading

LDH isoenzymes are sensitive to sample handling. If red blood cells rupture during or after the blood draw (a common occurrence called in vitro hemolysis, meaning the cells broke apart in the collection tube rather than in your body), LDH-1 and to a lesser extent LDH-2 will be falsely elevated, mimicking a cardiac injury pattern. This is one of the most frequent sources of misleading results. If your LDH isoenzyme pattern looks abnormal but you have no symptoms, ask whether the sample may have been hemolyzed.

Intense physical exercise, recent surgery, or acute illness such as infection can all raise total LDH and shift isoenzyme patterns temporarily. These are not necessarily signs of organ damage but rather reflections of normal physiological stress. If you have had any of these exposures in the few days before your blood draw, your results may not represent your baseline status.

Medications that cause muscle or liver damage as a side effect can elevate total LDH and shift isoenzyme patterns, but no research in the current evidence base identifies specific drugs that selectively alter LDH-2 without affecting the underlying biology. If you are on medications known to affect the liver or muscles (such as statins or certain antibiotics), mention this when interpreting your results.

Tracking Your Trend

A single LDH-2 reading is a snapshot. Because so many transient factors can shift the number, a lone result, especially one that is mildly abnormal, should prompt a retest before any conclusions are drawn. The real value of LDH isoenzymes comes from serial measurement: tracking the pattern over time, particularly during treatment for a known condition.

If you are monitoring a condition where LDH matters (such as cancer treatment response, recovery from a heart event, or tracking hemolysis in a blood disorder), retesting at intervals your clinician recommends, often every few weeks to months, lets you see whether the trajectory is improving. For a baseline in someone without a known condition, a single normal result is generally reassuring. If abnormal, retest in two to four weeks after ruling out sample-handling issues and transient confounders.

What to Do With an Abnormal Result

If your LDH-2 is elevated or your LDH-1 to LDH-2 ratio is flipped, the next step depends on the clinical context. A flipped ratio in someone with chest pain days ago should prompt cardiac evaluation, including high-sensitivity troponin, an electrocardiogram, and possibly imaging. If the elevation appears to come from white blood cell destruction, a complete blood count (CBC) with differential, a peripheral blood smear, and evaluation of spleen size may be warranted.

When the isoenzyme pattern suggests liver involvement (elevated LDH-5, another isoenzyme concentrated in the liver), liver function tests such as ALT (alanine aminotransferase), AST (aspartate aminotransferase), and GGT (gamma-glutamyl transferase) should be checked. If the pattern is ambiguous or you have no obvious symptoms, repeating the test and ordering total LDH alongside a comprehensive metabolic panel will help narrow the possibilities. Consider involving a hematologist if hemolysis is suspected, or a cardiologist if the cardiac pattern is present.